Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Nursing | Oncology | Pediatrics | Psychiatry | Journal

Back to Journal Articles

Health-Related QoL Evaluated for Children With Brain Tumors

Last Updated: May 09, 2012.

 

Patient and parent assessments correlate well; affected by disease type and treatment intensity

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
In children and adolescents with brain tumors treated with proton radiation, health-related quality of life scores are affected by both disease type and treatment, with assessments made by the patients correlating well with those of their parents, according to a study published online May 7 in the Journal of Clinical Oncology.

WEDNESDAY, May 9 (HealthDay News) -- In children and adolescents with brain tumors treated with proton radiation, health-related quality of life (HRQoL) scores are affected by both disease type and treatment, with assessments made by the patients correlating well with those of their parents, according to a study published online May 7 in the Journal of Clinical Oncology.

Karen A. Kuhlthau, Ph.D., of Massachusetts General Hospital in Boston, and colleagues conducted a prospective study to evaluate the HRQoL of 142 pediatric patients, aged 2 to 18 years, with brain tumors, who were treated with proton radiotherapy. The HRQoL assessments were made using the PedsQL core, brain tumor, and cancer modules, with scores ranging from 0 to 100. Both child self-report (CSR) and parent proxy report (PPR) were utilized.

For the core and brain tumor modules, the researchers found that the ratings of HRQoL from parents and children correlated well, although parent reports were generally lower than those of their children (74.8 and 78.1, respectively, for CSR and 67.0 and 74.8, respectively, for PPR). Disease type was associated with PPR core total HRQoL score at the start of treatment, with the lowest scores for medulloblastoma or primitive neuroectodermal tumors and the highest scores for low-grade glioma or other low-grade neoplasms. HRQoL was lower for those also receiving craniospinal irradiation and chemotherapy.

"This prospective study of children with brain tumors treated with proton radiation demonstrates the effect on HRQoL of disease type and intensity of treatment," the authors write.

One author disclosed financial ties to ProCure.

Abstract
Full Text (subscription or payment may be required)
Editorial

Copyright © 2012 HealthDay. All rights reserved.


Previous: Metformin May Have Dual Effect in Breast Cancer Next: Infectious Agents Cause About One in Six Cancers Worldwide

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.